MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a chronic neurodegenerative disease characterized by the pathological deposition of extracellular amyloid plaques and intraneuronal hyperphosphorylated tau tangles, as well as a prominent microglia activation responding to neuropathology and neurodegeneration [1–3].